The relationship between host immune status and cancer cells is incompletely understood, and there has been a significant recent interest in the interaction between cancer and the host’s immune status (e.g., CD4+ count, CD8+ count, CD4: CD8 ratio, and CD56+ fraction of peripheral lymphocytes) [22,23,24,25,26,27]. This evidence concerns the gene NCAM1 and cancer.